Similar to the effects of ESRRG knockdown, the ERRγ antagonists DN200434 and GSK5182 strongly inhibited the growth of a panel of SCLC cells (Fig. 2E,F; Appendix Fig. S2G–H). This evidence concerns the gene ESRRG and small cell lung carcinoma.